Back to Authors

Koch, Gary

Mayo Clinic

From the Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (V.E.T.); the Section of Nephrology, University of Chicago, Chicago (A.B.C.); the Institute of Physiology, University of Zurich, Zurich, Switzerland (O.D.); the Division of Nephro

Citations 1

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine | November 4, 2017 | Volume: 377 | Issue: 20 | Pages: 1930-1942

10.1056/nejmoa1710030 | PMID 29105594